Alexion crowns myasthenia gravis as its best Soliris launch ever
admin 24th October 2018 Uncategorised 0At the very beginning of 2018, Alexion figured its new Soliris approval in generalized myasthenia gravis could deliver its lead drug’s best launch. Now, as its third-quarter numbers show, that expectation has become a reality.
More: Alexion crowns myasthenia gravis as its best Soliris launch ever
Source: fierce